# Biomat USA Inc – FDA Inspection, Feb 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e7639e92-77a4-401a-893c-182ca4104731
Source feed: FDA_Inspections

> FDA inspection 1083848 of Biomat USA Inc, February 25, 2019. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083848
- Company Name: Biomat USA Inc
- Inspection Date: 2019-02-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 931693 - 2015-06-05
- FDA Inspection 779545 - 2012-04-30
- FDA Inspection 682767 - 2010-09-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7ec0f9db-4fd4-486c-8938-60ccc2a07326

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d